CARMEL, Ind., Sept. 26, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies that ...
Community funded, multidisciplinary study combines nerve growth drug plus Estim to target recovery after spinal cord injury in a large animal model. This combination approach to SCI maximizes spinal ...
Amber Therapeutics Ltd. has raised $100 million in a series A funding round to further develop its implantable closed-loop bioelectrical therapy to treat women suffering from mixed urinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results